PT1366033E - Compostos quimicos - Google Patents
Compostos quimicosInfo
- Publication number
- PT1366033E PT1366033E PT01994312T PT01994312T PT1366033E PT 1366033 E PT1366033 E PT 1366033E PT 01994312 T PT01994312 T PT 01994312T PT 01994312 T PT01994312 T PT 01994312T PT 1366033 E PT1366033 E PT 1366033E
- Authority
- PT
- Portugal
- Prior art keywords
- chemical compounds
- formula
- compounds
- present
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- External Artificial Organs (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0102408.2A GB0102408D0 (en) | 2001-01-31 | 2001-01-31 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1366033E true PT1366033E (pt) | 2005-08-31 |
Family
ID=9907834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01994312T PT1366033E (pt) | 2001-01-31 | 2001-12-17 | Compostos quimicos |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1366033B1 (pt) |
| JP (1) | JP2004521895A (pt) |
| KR (1) | KR20030070923A (pt) |
| CN (1) | CN1487928A (pt) |
| AT (1) | ATE294167T1 (pt) |
| AU (1) | AU2002246720B2 (pt) |
| BR (1) | BR0116854A (pt) |
| CA (1) | CA2434853A1 (pt) |
| CZ (1) | CZ20032085A3 (pt) |
| DE (1) | DE60110468T2 (pt) |
| DK (1) | DK1366033T3 (pt) |
| ES (1) | ES2240557T3 (pt) |
| GB (1) | GB0102408D0 (pt) |
| HK (1) | HK1060883A1 (pt) |
| HU (1) | HUP0303026A3 (pt) |
| IL (2) | IL156639A0 (pt) |
| MX (1) | MXPA03006847A (pt) |
| NO (1) | NO20033401L (pt) |
| NZ (1) | NZ526846A (pt) |
| PL (1) | PL363359A1 (pt) |
| PT (1) | PT1366033E (pt) |
| WO (1) | WO2002060885A1 (pt) |
| ZA (1) | ZA200305770B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0102407D0 (en) * | 2001-01-31 | 2001-03-14 | Glaxo Group Ltd | Process |
| US7709677B2 (en) | 2001-01-31 | 2010-05-04 | Glaxosmithkline Llc | Process of preparing arylethanoldiamines |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9207964D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Chemical compounds |
| AU2737295A (en) * | 1994-06-09 | 1996-01-04 | Glaxo Group Limited | Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists |
| GB9525177D0 (en) * | 1995-12-08 | 1996-02-07 | Glaxo Group Ltd | Chemical compounds |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
-
2001
- 2001-01-31 GB GBGB0102408.2A patent/GB0102408D0/en not_active Ceased
- 2001-12-17 MX MXPA03006847A patent/MXPA03006847A/es active IP Right Grant
- 2001-12-17 BR BR0116854-1A patent/BR0116854A/pt not_active Application Discontinuation
- 2001-12-17 AT AT01994312T patent/ATE294167T1/de not_active IP Right Cessation
- 2001-12-17 IL IL15663901A patent/IL156639A0/xx active IP Right Grant
- 2001-12-17 DK DK01994312T patent/DK1366033T3/da active
- 2001-12-17 CZ CZ20032085A patent/CZ20032085A3/cs unknown
- 2001-12-17 WO PCT/US2001/049299 patent/WO2002060885A1/en active IP Right Grant
- 2001-12-17 DE DE60110468T patent/DE60110468T2/de not_active Expired - Lifetime
- 2001-12-17 HU HU0303026A patent/HUP0303026A3/hu unknown
- 2001-12-17 CA CA002434853A patent/CA2434853A1/en not_active Abandoned
- 2001-12-17 KR KR10-2003-7010057A patent/KR20030070923A/ko not_active Application Discontinuation
- 2001-12-17 EP EP01994312A patent/EP1366033B1/en not_active Expired - Lifetime
- 2001-12-17 AU AU2002246720A patent/AU2002246720B2/en not_active Ceased
- 2001-12-17 JP JP2002561035A patent/JP2004521895A/ja active Pending
- 2001-12-17 CN CNA018224415A patent/CN1487928A/zh active Pending
- 2001-12-17 NZ NZ526846A patent/NZ526846A/en unknown
- 2001-12-17 PT PT01994312T patent/PT1366033E/pt unknown
- 2001-12-17 PL PL01363359A patent/PL363359A1/xx not_active Application Discontinuation
- 2001-12-17 ES ES01994312T patent/ES2240557T3/es not_active Expired - Lifetime
-
2003
- 2003-06-25 IL IL156639A patent/IL156639A/en not_active IP Right Cessation
- 2003-07-25 ZA ZA200305770A patent/ZA200305770B/en unknown
- 2003-07-30 NO NO20033401A patent/NO20033401L/no unknown
-
2004
- 2004-05-28 HK HK04103858A patent/HK1060883A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1060883A1 (en) | 2004-08-27 |
| NZ526846A (en) | 2004-10-29 |
| EP1366033B1 (en) | 2005-04-27 |
| NO20033401L (no) | 2003-09-30 |
| DE60110468T2 (de) | 2006-02-23 |
| MXPA03006847A (es) | 2003-11-13 |
| AU2002246720B2 (en) | 2004-07-22 |
| CN1487928A (zh) | 2004-04-07 |
| KR20030070923A (ko) | 2003-09-02 |
| BR0116854A (pt) | 2004-02-25 |
| CA2434853A1 (en) | 2002-08-08 |
| DK1366033T3 (da) | 2005-08-15 |
| HUP0303026A3 (en) | 2007-06-28 |
| WO2002060885A1 (en) | 2002-08-08 |
| PL363359A1 (en) | 2004-11-15 |
| ES2240557T3 (es) | 2005-10-16 |
| GB0102408D0 (en) | 2001-03-14 |
| ZA200305770B (en) | 2004-10-25 |
| ATE294167T1 (de) | 2005-05-15 |
| IL156639A0 (en) | 2004-01-04 |
| CZ20032085A3 (cs) | 2003-12-17 |
| JP2004521895A (ja) | 2004-07-22 |
| NO20033401D0 (no) | 2003-07-30 |
| EP1366033A1 (en) | 2003-12-03 |
| HUP0303026A2 (hu) | 2003-12-29 |
| IL156639A (en) | 2006-12-31 |
| DE60110468D1 (de) | 2005-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200601552A1 (ru) | Замещенные конденсированные гетероциклические с-гликозиды | |
| EA200601555A1 (ru) | Замещенные индазол-о-глюкозиды | |
| EA200601554A1 (ru) | Замещенные индол-о-глюкозиды | |
| EA200501771A1 (ru) | Лиганды каннабиноидных рецепторов и их применения | |
| ATE449097T1 (de) | Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer | |
| UA86042C2 (en) | Substituted indazole-o-glucosides | |
| BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
| ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
| DE60207890D1 (de) | Neue verbindungen | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| PT1267869E (pt) | Antogonistas de receptor de glutamato metabotropico para o tratamento de tolerancia e de dependencia | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| SE0302304D0 (sv) | Novel compounds | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| DK1366033T3 (da) | Kemiske forbindelser | |
| SE0302361D0 (sv) | Inhibering av upptagning av monoamin | |
| ATE391489T1 (de) | Haarbehandlungszusammensetzungen | |
| ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
| SE0202608D0 (sv) | New sequences | |
| DE60215947D1 (de) | Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht |